{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-059413","form_type":"8-K","ticker":"ATEC","cik":"0001350653","company_name":"Alphatec Holdings, Inc.","filed_at":"2023-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.728678+00:00","generated_at":"2026-06-08T19:21:56.976219+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ATEC Q3 revenue up 32% to $118M; raises FY2023 adjusted EBITDA guidance to ~$3M","bullets":["Total revenue $118M (+32% YoY); surgical revenue $104M (+32%), EOS $14M (+30%).","GAAP operating loss ($38M) but positive adjusted EBITDA of $2M, second consecutive quarter.","Raises FY2023 adjusted EBITDA guidance to ~$3M; revenue guidance unchanged at $472M (+35%).","Ended Q3 with $123M cash; secured $150M capital to invest in revenue-generating assets.","Inducement grants of 24,296 RSUs to 13 new non-executive employees."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-059413","json":"https://secwatch.observer/filing/0000950170-23-059413.json","markdown":"https://secwatch.observer/filing/0000950170-23-059413.md","text":"https://secwatch.observer/filing/0000950170-23-059413.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1350653/000095017023059413/0000950170-23-059413-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1350653/000095017023059413/atec-20231106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T19:21:56.976219+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ab8c7a8ab1cf77ac4e67f5e05bf45d76e3783dc","claim":"Alphatec Holdings, Inc. reported the fiscal year ended December 31, 2023 results: revenue $472 million. Guidance raised.","evidence_excerpt":"operational excellence that ATEC is renowned for. Our best is yet to come.” Financial Outlook for the Full Year 2023 The Company continues to expect total revenue to grow 35% to $472 million for the fiscal year ended December 31, 2023, in line with the expectations previewed in conjunction with the release of preliminary third quarter financial results. This includes","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1350653/000095017023059413/0000950170-23-059413-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$472 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"68ce872b158306b079c6a5660b9bc8ceb6810307","claim":"Alphatec Holdings, Inc. reported the quarter ended September 30, 2023 results: revenue $118 million. Guidance raised.","evidence_excerpt":"--- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance Total revenue grew 32% to $118 million Surgical revenue grew 32% to $104 million and EOS revenue grew 30% to $14 million Delivered positive adjusted EBITDA of over $2 million CARLSBAD, Calif., November 6, 2023 –","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1350653/000095017023059413/0000950170-23-059413-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$118 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}